Regulatory Aspects of Gene Therapy and Cell Therapy Products : A Global Perspective (Advances in Experimental Medicine and Biology) （2ND）

個数：

Regulatory Aspects of Gene Therapy and Cell Therapy Products : A Global Perspective (Advances in Experimental Medicine and Biology) （2ND）

Galli, Maria Cristina (EDT)

ウェブストア価格 ¥25,172（本体¥22,884）
Springer International Publishing AG（2024/08発売）
外貨定価 US$ 119.99
ポイント 228pt

在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
通常6～9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合がございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 242 p.
言語 ENG
商品コード 9783031345692

Full Description

This book discusses the different regulatory pathways for Advanced Therapy Medicinal Products implemented by national agencies in North and South America, Europe and Asia and by international bodies in the effort of international harmonization.

This book represents an update of the first edition, as it covers regulatory novelties and accumulated experience in the regions already addressed. In addition, this new edition offers a wider international perspective: new chapters are included covering Advanced Therapy Medicinal Products regulations in India, Malaysia, Spain and Thailand, the European Pharmacopoeia texts for gene therapy medicinal products as well as international harmonization programs.

Each chapter, authored by experts from various regulatory bodies throughout the international community, walks the reader through the applications of nonclinical research to translational clinical research to licensure and therapeutic use of these innovative products. More specifically, each chapter offers insights into fundamental considerations that are essential for developers of Advanced Therapy Medicinal Products in the areas of product quality, pharmacology and toxicology, clinical trial design and HTA pathways, as well as pertinent 'must-know' guidelines and regulations.

Regulatory Aspects of Gene Therapy and Cell Therapy Products: a Global Perspective is part of the American Society of Gene & Cell Therapy sub-series of the highly successful Advances in Experimental Medicine and Biology series. It is essential reading for graduate students, clinicians, and researchers interested in gene and cell therapy and the regulation of pharmaceuticals.

Introduction (MCG and FN).- Updates on ATMP regulations from EU: experience with PRIME procedure and list of approved ATMP.- EU portal for clinical trials application.- European Pharmacopoeia texts on gene therapy medicinal products.- Updates on ATMP regulations from UK after Brexit and list of approved ATMP.- Updates on ATMP regulations from Switzerland and list of approved ATMP.- Updates on ATMP regulations from US FDA: experience with breakthrough/accelerated procedures and list of approved ATMP.- Updates on ATMP regulations from Canada and list of approved ATMP.- Updates on ATMP regulations from Brasil and list of approved ATMP.- Updates on ATMP regulations from Singapore and list of approved ATMP.- Updates on ATMP regulations from Japan: experience with new law and list of approved ATMP.- Updates on ATMP regulations from South Korea and list of approved ATMP.- Updates on ATMP regulations from Taiwan and list of approved ATMP.- Updates on ATMP regulations from Thailand and listof approved ATMP.- ATMP regulations in China and list of approved ATMP.- ATMP regulations in Australia and list of approved ATMP.- ATMP regulations in India and list of approved ATMP.- International harmonization programs.